Skip to main content
Equibles
KRRO logo

KRRO · Korro Bio, Inc. · Metrics

Track KRRO — free

Use KRRO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KRRO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.29 -0.15 (-1.59%) At close · Oct 21
Russell 2000 member Rebalance outlook locked
Market Cap
$136.80M
Shares
14.73M
Volume · Oct 21 116K Avg daily vol (3M) 149.92K

KRRO metrics

78 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$9.29
Market cap
$136.80M

Price action

20 metrics
Price change (1W)
+4.6%
Price change (30D)
-10.2%
Price change (3M)
-20.6%
Price change (6M)
-33.6%
Price change (YTD)
+16.0%
Price change (1Y)
-77.6%
Trailing year
Price change (5Y)
—
52-week high
$41.44
52-week low
$5.28
Change from 52-week high
-77.6%
Change from 52-week low
+75.9%
Annualized volatility
115.0%
Annualized volatility (3M)
76.1%
Beta
2.7
RSI (14D)
42.7
Price vs SMA 50
-18.7%
Price vs SMA 200
-21.2%
Avg volume (3M)
149,916
Relative volume
0.8
Average dollar volume
$1.66M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
14.73M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
9.1×
reciprocal yield 10.9%
EV / EBITDA
—
EV / EBIT
—
P / sales
57.4×
reciprocal yield 1.7%
P / book
1.3
reciprocal yield 75.5%
FCF yield
-49.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-78.0%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
16.5×
reciprocal yield 6.1%
EV / revenue historical average (5Y)
16.5×
reciprocal yield 6.1%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
—
Operating margin
-4,625.5%
Trailing 12 months
Net margin
-4,477.1%
Gross profit (TTM)
—
Operating profit (TTM)
−$110.18M
Net income (TTM)
−$106.64M
Trailing 12 months
Diluted EPS (TTM)
$-10.01
FCF margin
-2,865.9%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.25
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
$-10.30
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-10.00
Operating cash flow per diluted share (TTM)
$-6.06
Free cash flow per diluted share (TTM)
$-6.09
Capital expenditures per diluted share (TTM)
$0.03
R&D per diluted share (TTM)
$4.62
Stock compensation per diluted share (TTM)
—
Book value per share
$5.46

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$2.38M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+87.6%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
-29.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-103.3%
Return on assets
-65.2%
Debt / equity
0.0
Current ratio
9.6
EBITDA (TTM)
—
Free cash flow (TTM)
−$68.27M
Quick ratio
9.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$115.04M
Latest balance sheet
Cash & equivalents
$24.91M
Total assets
$163.45M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$67.95M
Capital expenditures (TTM)
$317,000
R&D (TTM)
$52.24M
SG&A (TTM)
—
Stock compensation (TTM)
$13.66M
R&D / revenue
2,193.1%
Stock compensation / revenue
—

Ownership (13F)

9 metrics
13F filers
107
13F filer change QoQ
+7
Institutional ownership
98.8%
Conviction holders (share of 13F filers)
3.8%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+6.6%
Holder tenure
5.2
Price vs estimated holder cost
-8.7%

Ownership (registered funds)

1 metrics
Index-fund ownership
8.3%

Short interest

3 metrics
Short interest
11.4%
Latest settlement · 6.6 days to cover
Days to cover
6.6d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$1.28M
Insider-sentiment score
45 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1703647 CUSIP 500946108 13F (30d) 12 filings 12 filers Visit website Investor relations